The Female Reproductive System

  • Chirukandath Gopinath
  • Vasanthi Mowat


The importance of various morphological features occurring in different species at different stages of oestrous or menstrual cycle is stressed. Other external factors such as age, nutrition, and stress on oestrous cycle are discussed. Induced lesions occurring in ovaries, uterus, cervix, and vagina in different species are included. A few inducible tumours of the female reproductive tract are also illustrated.


Mammary Gland Granulosa Cell Endometrial Hyperplasia Female Reproductive Tract Corpus Luteum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Westwood FR. The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol. 2008;36:375–84.PubMedCrossRefGoogle Scholar
  2. 2.
    Van Esch E, Cline JM, Buse E, Weinbauer GF. The macaque endometrium, with special reference to the cynomolgus monkey (Macaca fascicularis). Toxicol Pathol. 2008;36:67S–100.CrossRefGoogle Scholar
  3. 3.
    Gopinath C. Toxicology and pathology of female reproductive tract. Cell Biol Toxicol. 2013;29:131–41.PubMedCrossRefGoogle Scholar
  4. 4.
    Buse E, Zöller M, Van Esch E. The macaque ovary, with special reference to the cynomolgus macaque (Macaca fascicularis). Toxicol Pathol. 2008;36:24S–66.CrossRefGoogle Scholar
  5. 5.
    Chandra SA, Adler RR. Frequency of different estrous stages in purpose-bred beagles: a retrospective study. Toxicol Pathol. 2008;36:944–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Shiromizu K, Thorgeirsson SS, Mattison DR. Effect of cyclophosphamide on oocyte and follicle number in Sprague-Dawley rats, C57BL/6N and DBA/2N mice. Pediatr Pharmacol. 1984;4:213–21.Google Scholar
  7. 7.
    Mattison DR. Morphology of oocyte and follicle destruction by polycyclic aromatic hydrocarbons in mice. Toxicol Appl Pharmacol. 1980;53:249–59.PubMedCrossRefGoogle Scholar
  8. 8.
    Regan KS, Cline JM, Creasy D, Davis B, Foley GL, Lanning L, et al. STP position paper: ovarian follicular counting in the assessment of rodent reproductive toxicity. Toxicol Pathol. 2005;33:409–12.PubMedCrossRefGoogle Scholar
  9. 9.
    Muskhelishvili L, Wingard SK, Latendresse JR. Proliferating cell nuclear antigen—a marker for ovarian follicle counts. Toxicol Pathol. 2005;33:365–8.PubMedCrossRefGoogle Scholar
  10. 10.
    de Baker SBC, Tucker M. Changes in the reproductive organs of rats and dog treated with butyrophenones and related compounds. In: de Baker SBC, Boisser JR, Koll W, editors. Toxicology & side effects of psychotropic drugs, vol. 9. Amsterdam: Excerpta Medica; 1968. p. 113.Google Scholar
  11. 11.
    Losco PE, Poulet FM, Kaminska-McNamara GZ, Klein MF. Myocardial and reproductive system toxicity of SCH 351591, a selective phosphodiesterase-4 inhibitor, in CD-1 mice. Toxicol Pathol. 2010;38:568–82.PubMedCrossRefGoogle Scholar
  12. 12.
    Mirsky ML, Sivaraman L, Houle C, Potter DM, Chapin RE, Cappon GD. Histologic and cytologic detection of endocrine and reproductive tract effects of exemestane in female rats treated for up to twenty-eight days. Toxicol Pathol. 2011;39:589–605.PubMedCrossRefGoogle Scholar
  13. 13.
    Nelson LW, Kelly WA, Weikel Jr JH. Mesovarial leiomyomas in rats in a chronic toxicity study of mesuprine hydrochloride. Toxicol Appl Pharmacol. 1972;23:731–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Greaves P. Female genital tract in histopathology of preclinical toxicity studies. 4th Edn. Amsterdam, Academic Press: 2012. p. 667–723.Google Scholar
  15. 15.
    Arias M, Aschheim P. Hypophysectomy and ageing: primary or secondary ovarian senescence. Experientia. 1974;30:213.Google Scholar
  16. 16.
    Moon HD, Simpson LE, Li CH, Evans HM. Neoplasms in rats treated with pituitary growth hormone lll. Reproductive organs. Cancer Res. 1950;10:549–66.PubMedGoogle Scholar
  17. 17.
    Owen NV, Pierce EC, Anderson RC. Papillomatous growths on internal genitalia of bitches administered the synthetic estrogen trans-4,4′-dimethyl-′,-diethylstilbene. Toxicol Appl Pharmacol. 1972;21:582–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Gopinath C, Gibson WA. Mesovarian leiomyomas in the rat. Environ Health Perspect. 1987;73:107–13.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Long GG, Cohen IR, Gries CL, Young JK, Francis PC, Capen CC. Proliferative lesions of ovarian granulosa cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator. Toxicol Pathol. 2001;29:403–10.PubMedCrossRefGoogle Scholar
  20. 20.
    Baskin GB, Smith SM, Marx PA. Endometrial hyperplasia, polyps, and adenomyosis associated with unopposed estrogen in rhesus monkeys (Macaca mulatta). Vet Pathol. 2002;39:572–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Anderson RK, Gilmore CE, Schnelle GB. Utero-ovarian disorders associated with use of medroxyprogesterone in dogs. J Am Vet Med Assoc. 1965;146:1311–6.PubMedGoogle Scholar
  22. 22.
    Nelson LW, Kelly WA. Progestogen-related gross and microscopic changes in female beagles. Vet Pathol. 1976;13:143–56.PubMedGoogle Scholar
  23. 23.
    Gopinath C. Comparative endocrine carcinogenesis. In: Harvey PW, Rush KC, Cockburn A, editors. Endocrine and hormonal toxicology. Chichester: Wiley; 1999. p. 156.Google Scholar
  24. 24.
    O’Shea JD, Jabara AG. Proliferative lesions of serous membranes in ovariectomised female and entire male dogs after stilboestrol administration. Vet Pathol. 1971;8:81–90.PubMedGoogle Scholar
  25. 25.
    Wadsworth PF, Heywood R, Allen DG, Sortwell RJ, Walton RM. Treatment of rhesus monkeys (Macaca mulatta) with intrauterine devices loaded with levonorgestrel. Contraception. 1979;20:177–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Huseby RA, Thurlow S. Effects of prenatal exposure of mice to “low-dose” diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia. Am J Obstet Gynecol. 1982;144:939–49.PubMedGoogle Scholar
  27. 27.
    Mori T, Nagasawa H. Mechanisms of development of prolactin-induced adenomyosis in mice. Acta Anat (Basel). 1983;116:46–54.CrossRefGoogle Scholar
  28. 28.
    Losco PE, Leach MW, Sinha D, Davis P, Schmahai TJ, Nomier A, et al. Administration of an antagonist of neurokinin receptors 1, 2, and 3 results in reproductive tract changes in beagle dogs, but not rats. Toxicol Pathol. 2007;35:310–22.PubMedCrossRefGoogle Scholar
  29. 29.
    Lipschutz A, Iglesias R, Panasevich VI, Salinas S. Pathological changes induced in the uterus of mice with prolonged administration of progesterone and 19-nor-contraceptives. Br J Cancer. 1967;21:160–5.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Annon. PERMAX (pergolide mesylate) prescribing information. Auckland: Eli Lilly; 2005.Google Scholar
  31. 31.
    Yoshida M, Katashima J, Ando T, Tanaka T, Uematsu F, Nakae D, et al. Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N′-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism. Carcinogenesis. 2004;25:2257–64.PubMedCrossRefGoogle Scholar
  32. 32.
    Gibson JP, Sells DM, Cheng HC, Yuk L. Induction of uterine leiomyomas in mice by medroxalol and prevention by propranolol. Toxicol Pathol. 1987;15:468–73.PubMedCrossRefGoogle Scholar
  33. 33.
    Lewis DJ, Gopinath C. The female reproductive system. In: Turton J, Hooson J, editors. Target organ pathology. London: Taylor & Francis; 1998. p. 407.Google Scholar
  34. 34.
    Sells DM, Gibson JP. Carcinogenicity studies with medroxalol hydrochloride in rats and mice. Toxicol Pathol. 1987;15:457–67.PubMedCrossRefGoogle Scholar
  35. 35.
    Rehm S, Solleveld HA, Portelli ST, Wier PJ. Histologic changes in ovary, uterus, vagina, and mammary gland of mature beagle dogs treated with the SERM idoxifene. Birth Defects Res B Dev Reprod Toxicol. 2007;80:225–32.PubMedCrossRefGoogle Scholar
  36. 36.
    Wadsworth PF, Heywood R, Allen DG, Hossack DJ, Sortwell RJ, Walton RM. Treatment of rhesus monkeys (Macaca mulatta) with intravaginal rings impregnated with either progesterone or norethisterone. Contraception. 1979;20:339–51.PubMedCrossRefGoogle Scholar
  37. 37.
    Wadsworth PF, Heywood R, Allen DG, Hossack DJ, Sortwell RJ, Walton RM. Treatment of rhesus monkeys (Macaca mulatta) with intravaginal rings loaded with levonorgestrel. Contraception. 1979;20:559–67.PubMedCrossRefGoogle Scholar
  38. 38.
    Eckstein P, Jackson MC, Millman N, Sobrero AJ. Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. J Reprod Fertil. 1969;20:85–93.PubMedCrossRefGoogle Scholar
  39. 39.
    Cline JM, Wood CE. The mammary glands of macaques. Toxicol Pathol. 2008;36:130S–41.CrossRefGoogle Scholar
  40. 40.
    Chandra SA, Mark CJ, Adler RR. Cyclic morphological changes in the beagle mammary gland. Toxicol Pathol. 2010;38:969–83.PubMedCrossRefGoogle Scholar
  41. 41.
    Heywood R, Wardsworth PF. The experimental toxicology of estrogens. In: Chaudhury RR, editor. Pharmacology of estrogens. International encyclopedia of pharmacology and therapeutics, Sect. 106. New York: Pergamon; 1981. p. 68.Google Scholar
  42. 42.
    Nelson LW, Weikel Jr JH, Leno FE. Mammary nodules in dogs during four years treatment with megestrol acetate of chlormadinone acetate. J Natl Cancer Inst. 1973;51:1303–11.PubMedGoogle Scholar
  43. 43.
    Horowski R, Graf KJ. Neuroendocrine effects of neuropsychotropic drugs and their possible influence on toxic reactions in animals and man. Arch Toxicol Suppl. 1979;2:93.PubMedCrossRefGoogle Scholar
  44. 44.
    Graf KJ, Freidreich E, Matties S, Hassman SH. Homologous radioimmunoassay for canine prolactin and its application in various physiological states. J Endocrinol. 1977;75:93–103.PubMedCrossRefGoogle Scholar
  45. 45.
    Gopinath C, Prentice DE, Lewis DJ. The reproductive system. In: Atlas of experimental toxicological pathology. Lancaster: MTP Press Ltd; 1987. p. 91–103.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Chirukandath Gopinath
    • 1
  • Vasanthi Mowat
    • 2
  1. 1.Consultant in Toxicology and PathologyCambridgeshireUK
  2. 2.Huntingdon Life SciencesCambridgeshireUK

Personalised recommendations